Ra Capital Management, L.P. Arcellx, Inc. Transaction History
Ra Capital Management, L.P.
- $4.82 Billion
- Q1 2025
A detailed history of Ra Capital Management, L.P. transactions in Arcellx, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 3,036,527 shares of ACLX stock, worth $219 Million. This represents 4.14% of its overall portfolio holdings.
Number of Shares
3,036,527
Previous 2,787,327
8.94%
Holding current value
$219 Million
Previous $212 Million
6.16%
% of portfolio
4.14%
Previous 3.44%
Shares
4 transactions
Others Institutions Holding ACLX
# of Institutions
213Shares Held
48.7MCall Options Held
764KPut Options Held
296K-
Paradigm Biocapital Advisors LP New York, NY4.49MShares$324 Million15.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.99MShares$287 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$270 Million23.3% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$253 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.93MShares$211 Million8.03% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.16B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...